Genentech, Immunogen get gastric cancer Orphan designation for Kadcyla

Kadcyla (RHHBY, IMGN) gets an Orphan Designation for the treatment of gastric cancer including gastroesophageal junction cancer.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs